N-(2-Methylphenyl)-5-(4-nitrophenyl)-4,5-dihydro-1,3-thiazol-2-amine, 97%, 100mg

2-(2-Iodoethyl)-1,3-dioxolane, 96.0%, 5g

4-Chloro-2-(4-methylpiperazin-1-yl)benzoic acid, 95.0%, 1g

6-Chloropurine, 98.0%, 500g

1-(4-Bromophenyl)-5-oxopyrrolidine-3-carboxylic acid, 97.0%, 5g

ROTI®Liquid Barrier Marker, colourless, 50 ml, 5 x 10 ml

tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate, 95.0%, 250mg

(2R,3S)-Dimethyl 2,3-dihydroxysuccinate, 98.0%, 25g

3,3'-(Propane-1,3-diylbis(oxy))bis(propan-1-ol), 98%, 250mg

3-((4-Acetylpiperazin-1-yl)sulfonyl)benzoic acid, 98%, 25g

1-(Tetrahydro-2H-pyran-2-yl)-5-(trifluoromethyl)-1H-indazol-4-amine, 97.0%, 1g

1-tert-butyl 3-methyl 4-methylpiperazine-1,3-dicarboxylate, 98%, 500mg

1-(Indolin-1-yl)ethanone, 95.0%, 500g